HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Nandrolone (Nortestosterone)

C18 steroid with androgenic and anabolic properties. It is generally prepared from alkyl ethers of ESTRADIOL to resemble TESTOSTERONE but less one carbon at the 19 position.

Also Known As:

Nortestosterone; 17-Hydroxy-Estr-4-Ene-3-One; 17beta-Hydroxy-19-Nor-4-Androsten-3-One; 17beta Hydroxy 19 Nor 4 Androsten 3 One; 19-Nortestosterone; Estrenolone; Norandrostenolone; Estr-4-en-3-one, 17-hydroxy-, (17beta)-

Networked: 191 relevant articles (14 outcomes, 21 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Pan, Jiangping: 7 articles (01/2015 - 01/2008)
2.	Bauman, William A: 7 articles (01/2015 - 01/2008)
3.	Wu, Yong: 6 articles (01/2015 - 01/2008)
4.	Qin, Weiping: 5 articles (01/2015 - 01/2010)
5.	Cardozo, Christopher P: 5 articles (11/2012 - 01/2010)
6.	Tanno, Ana Paula: 3 articles (05/2013 - 06/2006)
7.	Cardozo, Christopher: 2 articles (01/2015 - 01/2008)
8.	Scaccianoce, Sergio: 2 articles (01/2014 - 06/2010)
9.	das Neves, Vander José: 2 articles (05/2013 - 10/2011)
10.	Cunha, Tatiana Sousa: 2 articles (05/2013 - 10/2011)

Related Diseases

1.	Anemia 01/01/1977 - "Randomized study of nandrolone therapy for anemias due to bone marrow failure." 08/01/1981 - "[19-norandrostenolone undecylate in the treatment of anemia in patients treated with periodic hemodialysis]." 01/01/2012 - "This study has designed to see the efficacy of Nandrolone, a cheaper alternative; in comparison with recombinant human erythropoietin for management of anemia of pre-dialysis diabetic chronic kidney disease. " 01/01/2012 - "Nandrolone, though not equally effective, may be considered as a valid alternative therapy for the treatment of anemia of pre-dialysis diabetic chronic kidney disease to that of erythropoietin." 01/01/1977 - "One patient with myelofibrosis improved dramatically with placebo therapy alone, no longer requiring frequent transfusions because of a hemoglobin level increase from 5.4 to 15.8 gm/100 ml. We conclude that no substantial improvement of anemia due to marrow failure can be ascribed to nandrolone as given, and that clinical trials in these conditions should be controlled to exclude spontaneous remissions as a cause of apparent improvement."
2.	Pain (Aches) 12/01/1994 - "Pain intensity was significantly decreased in the nandrolone group and mobility was improved. " 01/01/2004 - "One trial (43 participants) found that intramuscular injections of the anabolic steroid nandrolone phenylpropionate significantly improved both pain and function compared to placebo injections. "
3.	Hypertrophy 01/01/2015 - "At the 10 µl dose of nandrolone, neural hypertrophy and increased dentate gyrus volume were also observed. " 02/01/2010 - "Our results suggest that satellite cells may be key cellular vectors for nandrolone induced muscle fiber hypertrophy." 02/01/2010 - "Although increases in satellite cell numbers and satellite cells giving rise to new myonuclei are associated with hypertrophy in many experimental models, the relationship between nandrolone and satellite cells is poorly understood. " 06/01/2006 - "[Nandrolone administration does not promote hypertrophy of soleus muscle in rats]." 10/01/1997 - "To study the effects of nandrolone laureate (19-nortestosterone) on muscle hypertrophy and concentration of androgen receptors (AR), biopsy specimens were taken from the middle gluteal muscle of 6 Finnhorse trotters (geldings and mares) undergoing training before, immediately after, and 13 weeks after a 14-week treatment with nandrolone. "
4.	Weight Gain 01/01/1983 - " Macrodosed progestagen pills taken in 20-day cycles appear to be an interesting alternative, but those with the most constant antigonadotropic activity are derived from nortestosterone and all have to some degree an anabolizing androgenic effect which may result in weight gain. " 03/01/1999 - "The aim of this study was to evaluate the potential mechanisms underlying the improved contractility of the diaphragm (Dia) in adult intact male hamsters after nandrolone (Nan) administration, given subcutaneously over 4 wk via a controlled-release capsule (initial dose: 4.5 mg. kg-1. day-1; with weight gain, final dose: 2.7 mg. kg-1. day-1). " 02/01/1993 - " Progestins derived from nortestosterone are anabolizing compounds and may cause significant weight gain. "
5.	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/01/1983 - "Ten patients (8 female, 2 male) with systemic lupus erythematosus (SLE) were entered into an open trial with the anabolic steroid 19-nortestosterone (19-nor). " 04/01/1983 - "Hormonal manipulation of the immune response in systemic lupus erythematosus: a drug trial of an anabolic steroid, 19-nortestosterone." 04/01/1992 - "Experience with 19-nortestosterone in the therapy of systemic lupus erythematosus: worsened disease after treatment with 19-nortestosterone in men and lack of improvement in women."

Related Drugs and Biologics

1.	Testosterone (Sustanon)
2.	Erythropoietin
3.	Hemoglobin A
4.	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)
5.	Medroxyprogesterone Acetate (Depo-Provera)
6.	Esters
7.	Cyclosporine (Ciclosporin)
8.	salicylhydroxamic acid (SHAM)
9.	Calcineurin
10.	Spironolactone (Aldactone)

Related Therapies and Procedures

1.	Denervation
2.	Intramuscular Injections
3.	Injections
4.	Contraception (Birth Control)
5.	Blood Transfusion (Blood Transfusions)